Who are Bolt Biotherapeutics, Inc.'s major customers?

Bolt Biotherapeutics, Inc. (BOLT) key customers include: GENMAB, TORAY-INDUSTRIES-INC, Genmab A/S, Genmab A/S. View the full customer network at chainsifter.com/chain/BOLT.

What sector is Bolt Biotherapeutics, Inc. in?

Bolt Biotherapeutics, Inc. (BOLT) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Bolt Biotherapeutics, Inc. (BOLT) Suppliers & Customers

0Suppliers

4Customers

3Debt Items

12Related Chains

Source-Backed Evidence Depth

Bolt Biotherapeutics, Inc. (BOLT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

8Total relationships

1Distinct source URLs

8High confidence

0.888Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Bolt Biotherapeutics, Inc. Suppliers

No suppliers on recordBolt Biotherapeutics, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Bolt Biotherapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
GENMAB	GENMAB	90%	The Company determined that the Genmab Agreement is a contract with a customer and should be accounted for under ASC 606.
TORAY-INDUSTRIES-INC	TORAY-INDUSTRIES-INC	90%	The Company determined that the Toray Agreement is a contract with a customer and should be accounted for under ASC 606.
GNMSF	Genmab A/S	85%	Reciprocal relationship from GNMSF graph: Reciprocal relationship from BOLT graph: Reciprocal relationship from GNMSF graph: Reciprocal relationship from BOLT graph: s covered under the agreement as …
GNMSF	Genmab A/S	85%	s covered under the agreement as a whole. Such optional additional items will be accounted for as contract modifications when development advances past certain milestones and the parties both exercis…

Bolt Biotherapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
BOLT-DEBT	Debt stack $22.3M	90%	Market cache reports total debt of $22.3M.
BOLT-DEBT-8324	Warrants outstanding: 0.07	90%	xbrl warrant detail from xbrl 2018-07-31.
BOLT-DEBT-8325	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2021-12-31.

Bolt Biotherapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Bolt Biotherapeutics, Inc..

Bolt Biotherapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
BOLT-OWNER-VIVO-CAPITAL-LLC	Vivo Capital, LLC	90%	13F overlay lists Vivo Capital, LLC as top holder; 24 tracked holders.

Bolt Biotherapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
IMTX	Immatics N.V.	100.00	2
CRBP	Corbus Pharmaceuticals Holdings, Inc.	100.00	2
DAWN	Day One Biopharmaceuticals Inc	100.00	2
BCAX	Bicara Therapeutics Inc.	100.00	2
GMAB	Genmab A/S	100.00	2
GHRS	GH Research PLC	100.00	2
JNJ	Johnson & Johnson	100.00	2
GENMAB	GENMAB	60.75	1	['receiving']
SNYNF	Sanofi	50.00	2
CNTA	Centessa Pharmaceuticals plc	50.00	2
GNMSF	Genmab A/S	45.90	1	['customer']
MGNX	MacroGenics, Inc.	17.45	2

Bolt Biotherapeutics, Inc. Supply Chain